Connection
Benjamin Bitler to Mice, Knockout
This is a "connection" page, showing publications Benjamin Bitler has written about Mice, Knockout.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.057 |
|
|
|
-
Ota Y, Elizagaray ML, Gupta V, Fashemi BE, Akande M, Babu P, Thuthika PK, Lomonosova E, Brill J, Sun L, Sanders B, Kuroki LM, McCourt CK, Hagemann AR, Hagemann IS, Thaker PH, Mutch DG, Powell MA, Hyrc K, Verma P, Krais J, Bitler BG, Mullen MM, Khabele D. RAD52 is a therapeutic vulnerability for acquired PARP inhibitor resistance in ovarian cancer. JCI Insight. 2026 Nov 09; 11(21).
Score: 0.037
-
Wu S, Fatkhutdinov N, Fukumoto T, Bitler BG, Park PH, Kossenkov AV, Trizzino M, Tang HY, Zhang L, Gardini A, Speicher DW, Zhang R. SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells. Nat Commun. 2018 10 08; 9(1):4116.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|